MX2023012801A - Nueva formulacion. - Google Patents

Nueva formulacion.

Info

Publication number
MX2023012801A
MX2023012801A MX2023012801A MX2023012801A MX2023012801A MX 2023012801 A MX2023012801 A MX 2023012801A MX 2023012801 A MX2023012801 A MX 2023012801A MX 2023012801 A MX2023012801 A MX 2023012801A MX 2023012801 A MX2023012801 A MX 2023012801A
Authority
MX
Mexico
Prior art keywords
new formulation
formulation
etonogestrel
contraception
preparing
Prior art date
Application number
MX2023012801A
Other languages
English (en)
Spanish (es)
Inventor
Myriam Abbassi
Maria Ferrand
Sophie Lelamer
Elodie Rey
Lilian Santa
Original Assignee
Medincell Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medincell Sa filed Critical Medincell Sa
Publication of MX2023012801A publication Critical patent/MX2023012801A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2023012801A 2021-04-30 2022-04-29 Nueva formulacion. MX2023012801A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21305559 2021-04-30
PCT/EP2022/061511 WO2022229402A1 (en) 2021-04-30 2022-04-29 New formulation

Publications (1)

Publication Number Publication Date
MX2023012801A true MX2023012801A (es) 2023-11-08

Family

ID=75904839

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023012801A MX2023012801A (es) 2021-04-30 2022-04-29 Nueva formulacion.

Country Status (9)

Country Link
US (1) US20240325294A1 (https=)
EP (1) EP4329727A1 (https=)
JP (1) JP2024516264A (https=)
KR (1) KR20240006032A (https=)
CN (1) CN117222402A (https=)
AU (1) AU2022264844A1 (https=)
CA (1) CA3217538A1 (https=)
MX (1) MX2023012801A (https=)
WO (1) WO2022229402A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026013080A1 (en) 2024-07-08 2026-01-15 InnoCore Technologies Holding B.V. Pharmaceutical composition based on biodegradable polymers comprising polyoxazoline

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741628B1 (fr) 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
US9023897B2 (en) * 2010-12-29 2015-05-05 Medincell Biodegradable drug delivery compositions
CN103446043B (zh) * 2012-05-29 2015-06-17 辽宁省计划生育科学研究院 一种原位凝胶注射植入剂
EP2866837B1 (en) * 2012-06-27 2022-12-14 Medincell S.A. Biodegradable drug delivery for hydrophobic compositions
US10188602B2 (en) * 2016-09-29 2019-01-29 Gesea Biosciences Inc. Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
EP3655017B1 (en) * 2017-07-17 2025-01-22 Medincell S.A. Pharmaceutical composition
KR102441064B1 (ko) * 2017-07-17 2022-09-06 현대자동차주식회사 연료전지 차량의 제어 방법

Also Published As

Publication number Publication date
JP2024516264A (ja) 2024-04-12
WO2022229402A1 (en) 2022-11-03
AU2022264844A1 (en) 2023-11-23
EP4329727A1 (en) 2024-03-06
US20240325294A1 (en) 2024-10-03
CA3217538A1 (en) 2022-11-03
CN117222402A (zh) 2023-12-12
KR20240006032A (ko) 2024-01-12

Similar Documents

Publication Publication Date Title
ZA201902053B (en) Pharmaceutical composition
CL2016001411A1 (es) Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina.
BR112012023324B8 (pt) processo de preparação de uma forma de dosagem multifásica liofilizada de dissolução rápida
MX2021006969A (es) Ligante peptidico.
MX389310B (es) Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso.
WO2018165404A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
PE20211588A1 (es) Compuestos y sus usos para aliviar sintomas asociados a la menopausia
PH12020550815A1 (en) Delayed release deferiprone tablets and methods of using the same
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
MY208261A (en) Oral pharmaceutical composition
MX2023012801A (es) Nueva formulacion.
MX2021005390A (es) Ingredientes farmaceuticos activos amorfos novedosos que comprenden carbonato de magnesio mesoporoso sustancialmente amorfo.
JOP20240026A1 (ar) طريقة لعلاج بطانة الرحم وتوفير وسيلة فعالة لمنع الحمل
MX2018010065A (es) Forma de dosificacion oral que comprende rifaximina en forma beta.
MX2022006502A (es) Composiciones farmaceuticas.
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
ZA202003904B (en) Drug delivery system
MX2017013634A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
MX2017013643A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.
WO2020022976A3 (en) A formulation comprising dexketoprofen
ZA202303273B (en) New modified release oral contraceptive composition
PH12020551547A1 (en) Pharmaceutical preparation
MX2021010018A (es) Anticonceptivos unisex no hormonales.
MX2021004553A (es) Composiciones farmaceuticas y metodos para fabricar formulaciones de dosificacion solidas bajo demanda.